MARKET WIRE NEWS

Laboratorios Farmaceuticos Rovi, S.A. (LABFF) Acquisition Of An Injectable Drug Product Manufacturing Site In Phoenix, Arizona Call (Transcript)

Source: SeekingAlpha

2025-09-30 18:52:01 ET

Laboratorios Farmaceuticos Rovi, S.A. (LABFF) Acquisition Of An Injectable Drug Product Manufacturing Site In Phoenix, Arizona Call September 30, 2025 9:00 AM EDT...

Read the full article on Seeking Alpha

For further details see:

Laboratorios Farmaceuticos Rovi, S.A. (LABFF) Acquisition Of An Injectable Drug Product Manufacturing Site In Phoenix, Arizona Call (Transcript)
Laboratorios

NASDAQ: LABFF

LABFF Trading

100.0% G/L:

$65.8636 Last:

5 Volume:

$0 Open:

mwn-link-x Ad 300

LABFF Latest News

LABFF Stock Data

$3,449,409,315
52,372,013
N/A
N/A
Biotechnology & Life Sciences
Healthcare
ES

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App